Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
Ion CotarlaMarnie L BoronShawna L CullenDaryl S SpinnerEric C FaulknerMarissa C CarrollSurbhi ShahAdam Yagui-BeltranPublished in: JCO oncology practice (2020)
Oncologists reported notable deviations from treatment guidelines for stage III NSCLC. Our findings highlight important opportunities to improve decision making and the coordination of care in stage III NSCLC.